Richard Buick, PhD
Chief Scientific Officer
Richard Buick has more than 19 years’ experience in the biopharmaceutical industry. After graduating with a 1st Class Honours degree in Genetics, he spent 4 years at Randox Laboratories, discovering novel antibodies for diagnostics from synthetic libraries. Richard joined Fusion Antibodies in 2002, where he was responsible for overseeing the Company’s Contract Research Services and production of all reagents required for the research and development of internal drug assets. Richard has a PhD from Queen’s University Belfast in Immunology. He joined the Company as a Director and was appointed CTO in 2011, managing all scientific projects and Fusion Antibodies’ patent portfolios. In addition, Richard has, since 2015, been appointed as a legal expert witness in a number of drug patent dispute cases.